Search Results 71-80 of 16845 for Humira
TNF-alpha inhibitors including but not limited to infliximab (Remicade) or adalimumab (Humira) within 12 weeks of Day 0; Any biological agent within 12 weeks ...
The purpose of this study is to develop a laboratory test to determine if an individual is at risk of developing antibodies to one of these two monoclonal ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Identifying biomarkers associated with failure vs success of immunosuppressive treatments (DMARD) tapering is a critical need which will allow to maximize the ...
This phase III clinical trial is studying how well combination chemotherapy and surgery work in treating young patients with Bilateral Wilms tumor and children ...
The performance characteristics of the ddPCR assay for the detection of ctDNA mutation in uveal melanoma patients will be assessed by comparing the mutation ...
Serious eye or vision problems (eg, eye infection or bleeding, retinal detachment, or retinal vasculitis with or without occlusion) may occur with this medicine ...
Kern National Network for Caring and Compassion in Medicine Award Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery.
... Humira®, Cimzia™, Tysabri®, or Stelara®) are different from those among IBD - affected women not taking these medications. . Mayo Clinic Footer. Request ...
Ofatumumab injection is also used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.